TY  - JOUR

T1  - Comparative study of neoadjuvant chemotherapy with and without Zometa for management of locally advanced breast cancer with serum VEGF as primary endpoint: The NEOZOL study

JO  - Clinical Breast Cancer

UR  - http://eprints.whiterose.ac.uk/152917/

PY  - 2018/12/01

AU  - Lelièvre L

AU  - Clézardin P

AU  - Magaud L

AU  - Roche L

AU  - Tubiana-Mathieu N

AU  - Tigaud J-D

AU  - Topart D

AU  - Raban N

AU  - Mouret-Reynier M-A

AU  - Mathevet P

ED  - 

DO  - DOI: 10.1016/j.clbc.2018.07.005

PB  - Elsevier

VL  - 18

IS  - 6

SP  - e1311

EP  - e1321

Y2  - 2025/10/26

ER  -